BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 21561999)

  • 1. Regulation of serum 1,25(OH)2 vitamin D3 levels by fibroblast growth factor 23 is mediated by FGF receptors 3 and 4.
    Gattineni J; Twombley K; Goetz R; Mohammadi M; Baum M
    Am J Physiol Renal Physiol; 2011 Aug; 301(2):F371-7. PubMed ID: 21561999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1.
    Gattineni J; Bates C; Twombley K; Dwarakanath V; Robinson ML; Goetz R; Mohammadi M; Baum M
    Am J Physiol Renal Physiol; 2009 Aug; 297(2):F282-91. PubMed ID: 19515808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of renal phosphate transport by FGF23 is mediated by FGFR1 and FGFR4.
    Gattineni J; Alphonse P; Zhang Q; Mathews N; Bates CM; Baum M
    Am J Physiol Renal Physiol; 2014 Feb; 306(3):F351-8. PubMed ID: 24259513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGFR3 and FGFR4 do not mediate renal effects of FGF23.
    Liu S; Vierthaler L; Tang W; Zhou J; Quarles LD
    J Am Soc Nephrol; 2008 Dec; 19(12):2342-50. PubMed ID: 18753255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compound deletion of Fgfr3 and Fgfr4 partially rescues the Hyp mouse phenotype.
    Li H; Martin A; David V; Quarles LD
    Am J Physiol Endocrinol Metab; 2011 Mar; 300(3):E508-17. PubMed ID: 21139072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D and type II sodium-dependent phosphate cotransporters.
    Kido S; Kaneko I; Tatsumi S; Segawa H; Miyamoto K
    Contrib Nephrol; 2013; 180():86-97. PubMed ID: 23652552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo evidence for an interplay of FGF23/Klotho/PTH axis on the phosphate handling in renal proximal tubules.
    Ide N; Ye R; Courbebaisse M; Olauson H; Densmore MJ; Larsson TE; Hanai JI; Lanske B
    Am J Physiol Renal Physiol; 2018 Nov; 315(5):F1261-F1270. PubMed ID: 29993278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Convergent Signaling Pathways Regulate Parathyroid Hormone and Fibroblast Growth Factor-23 Action on NPT2A-mediated Phosphate Transport.
    Sneddon WB; Ruiz GW; Gallo LI; Xiao K; Zhang Q; Rbaibi Y; Weisz OA; Apodaca GL; Friedman PA
    J Biol Chem; 2016 Sep; 291(36):18632-42. PubMed ID: 27432882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleiotropic Actions of FGF23.
    Erben RG
    Toxicol Pathol; 2017 Oct; 45(7):904-910. PubMed ID: 29096595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic rats.
    Leifheit-Nestler M; Grabner A; Hermann L; Richter B; Schmitz K; Fischer DC; Yanucil C; Faul C; Haffner D
    Nephrol Dial Transplant; 2017 Sep; 32(9):1493-1503. PubMed ID: 28339837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D.
    Liu S; Tang W; Zhou J; Stubbs JR; Luo Q; Pi M; Quarles LD
    J Am Soc Nephrol; 2006 May; 17(5):1305-15. PubMed ID: 16597685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The calcium-sensing receptor has only a parathyroid hormone-dependent role in the acute response of renal phosphate transporters to phosphate intake.
    Daryadel A; Küng CJ; Haykir B; Sabrautzki S; de Angelis MH; Hernando N; Rubio-Aliaga I; Wagner CA
    Am J Physiol Renal Physiol; 2024 May; 326(5):F792-F801. PubMed ID: 38545651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor 23 leads to endolysosomal routing of the renal phosphate cotransporters NaPi-IIa and NaPi-IIc in vivo.
    Küng CJ; Haykir B; Schnitzbauer U; Egli-Spichtig D; Hernando N; Wagner CA
    Am J Physiol Renal Physiol; 2021 Dec; 321(6):F785-F798. PubMed ID: 34719948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease.
    Quarles LD
    Exp Cell Res; 2012 May; 318(9):1040-8. PubMed ID: 22421513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fibroblast growth factor (FGF) 23 works as a phosphate-regulating hormone and is involved in the pathogenesis of several disorders of phosphate metabolism].
    Fukumoto S
    Rinsho Byori; 2007 Jun; 55(6):555-9. PubMed ID: 17657990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF23 and syndromes of abnormal renal phosphate handling.
    Bergwitz C; Jüppner H
    Adv Exp Med Biol; 2012; 728():41-64. PubMed ID: 22396161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Klotho Lacks an FGF23-Independent Role in Mineral Homeostasis.
    Andrukhova O; Bayer J; Schüler C; Zeitz U; Murali SK; Ada S; Alvarez-Pez JM; Smorodchenko A; Erben RG
    J Bone Miner Res; 2017 Oct; 32(10):2049-2061. PubMed ID: 28600880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoids dexamethasone and prednisolone suppress fibroblast growth factor 23 (FGF23).
    Feger M; Ewendt F; Strotmann J; Schäffler H; Kempe-Teufel D; Glosse P; Stangl GI; Föller M
    J Mol Med (Berl); 2021 May; 99(5):699-711. PubMed ID: 33517471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fgf23 and parathyroid hormone signaling interact in kidney and bone.
    Andrukhova O; Streicher C; Zeitz U; Erben RG
    Mol Cell Endocrinol; 2016 Nov; 436():224-39. PubMed ID: 27498418
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.